Introduction and aims: Gastric cancer is one of the main causes of cancer worldwide, but there is currently no global screening strategy for the disease. Endoscopy is the screening method of choice in some Asian countries, but no standardized technique has been recognized. Systematic alphanumeric-coded endoscopy can increase gastric lesion detection. The aim of the present article was to compare the usefulness of systematic alphanumeric-coded endoscopy with conventional endoscopy for the detection of premalignant lesions and early gastric cancer in subjects at average risk for gastric cancer. Materials and methods: A cross-sectional, comparative, prospective, randomized study was conducted on patients at average risk for gastric cancer (40-50 years of age, no history of H. pylori infection, intestinal metaplasia, gastric atrophy, or gastrointestinal surgery). Before undergoing endoscopy, the patients had gastric preparation (200 mg of oral acetylcysteine or 50 mg of oral dimethicone). Conventional chromoendoscopy was performed with indigo carmine dye for contrast enhancement. ଝ Please cite this article as: Pérez-Mendoza A, Zárate-Guzmán ÁM, Galvis García ES, Sobrino Cossío S, Djamus Birch J. Aplicación de la endoscopia sistemática alfanumérica codificada más cromoendoscopia para la detección de lesiones precancerosas gástricas y cáncer gástrico temprano en sujetos con riesgo promedio de cáncer gástrico. Revista de Gastroenterología de México. 2018;83:117---124. (Á.M. Zárate-Guzmán). 2255-534X/© 2018 Asociación Mexicana de Gastroenterología. Published by Masson Doyma México S.A. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Results: Fifty consecutive cases (mean age 44.4 ± 3.34 years, 60% women, BMI 27.6 ± 5.82 kg/m 2 ) were evaluated. Endoscopic imaging quality was satisfactory in all the cases, with no differences between methods (p = 0.817). The detection rate of premalignant lesions and early gastric cancer was 14% (6 cases of intestinal metaplasia and one case of gastric adenocarcinoma). Sensitivity, specificity, positive predictive value, negative predictive value, and diagnostic accuracy were 100, 95, 80, 100 and 96%, respectively, for systematic alphanumericcoded endoscopy, and 100, 45, 20, 100, and 52%, respectively, for conventional endoscopy. Lesion detection through systematic alphanumeric-coded endoscopy was superior to that of conventional endoscopy (p = 0.003; OR = 12). Conclusion: Both techniques were effective, but systematic alphanumeric-coded endoscopy significantly reduced the false positive rate. 
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Introduction and aims
Gastric cancer is the third cause of cancer death (723,000 deaths/year), with 870,000 new cases reported in 2001. 1, 2 There is currently no universally accepted screening strategy for premalignant lesions. 3 Both noninvasive techniques (radiologic methods, H. pylori serology, and pepsinogen I, pepsinogen II, and serum gastrin determinations) and invasive techniques (endoscopy, magnification, chromoendoscopy, narrow band imaging, autofluorescence, and confocal laser endomicroscopy) have been proposed. 3 Intestinal metaplasia and gastric atrophy and dysplasia increase the risk for cancer. 4 The Paris Classification system has been accepted worldwide as a unified way to classify gastric lesions. 5 The interval gastric cancer rate (23.1%) has been related to lesion size and the presence of intestinal metaplasia. 6 ---8 Thorough examination and adequate cleansing of the gastric mucosa are essential for detecting said lesions in at-risk subjects. 9 Systematic alphanumeric-coded endoscopy (SACE) is a method for evaluating the gastric mucosa that divides the upper digestive tract into 8 regions and 28 areas ( Table 1 , fig. 1 ). It enables the examination of the entire surface through a system of coordinates based on the identification of certain natural axes, walls, curvatures, and anatomic reference points, preventing blind spots, and thus having a significant impact on the detection rate of premalignant lesions and the reduction of interval cancer. 9---11 The aim of the present study was to compare the usefulness of SACE with conventional endoscopy in the detection of premalignant lesions and early gastric cancer in subjects at average risk for gastric cancer. We defined patients at average risk as those between the ages of 40 and 50 years, with no associated factor that increased the risk for cancer.
Materials and methods
A cross-sectional, randomized, prospective study was conducted on patients at average risk for gastric cancer at the Hospital General de México ''Dr. Eduardo Liceaga''.
Selection criteria: a) inclusion criteria: healthy subjects between 40 and 50 years of age, both sexes, signed statements of informed consent, b) exclusion criteria: history of H. pylori infection, intestinal metaplasia, gastric atrophy or dysplasia, gastric surgery with resection, bowel obstruction, portal hypertension, and gastrointestinal bleeding.
Premedication
All patients underwent pre-endoscopic gastric cleansing (randomly assigned) through oral intake (20-30 min before the procedure) of dimethicone suspension (Espaven Pediatrics ® , 50 mg) or N-acetylcysteine (200 mg of granulated Lysomucil ® ) diluted in 100 ml of water. Gastric cleansing quality was evaluated through the following scores: 0 = no residue, the mucosa can be completely evaluated; 1 = some residue, all of which can be aspirated with the endoscope; 2 = thick liquid residue, needing irrigation with water to be dissolved, followed by complete aspiration; 3 = thick liquid residue, needing irrigation with water to be dissolved, followed by incomplete aspiration; 4 = solid residue that cannot be aspirated. The mean endoscopic study duration required was registered.
The patients were randomly assigned (random number table) to one of the two gastric examination groups: 1) conventional endoscopy or 2) SACE. 
Endoscopy equipment
GIF-Q145 (Japan 2000) and GIF-Q150 (Japan 2006) video gastroscopes, EVIS EXERA-II processor.
Chromoendoscopy and biopsy
The studies were performed by physicians in endoscopy training and supervised by staff physicians. In the SACE group, images were taken upon entrance, after completing additional cleansing of the gastric chamber (if necessary) to expose 100% of the mucosa, following the previously described coding ( Table 1 , fig. 1 ). Premalignant lesion was defined as a lesion having any of the following characteristics: polypoid or ulcerous, Paris 0-IIa and 0-IIc lesions, change in coloring (reddish or whitish), or markedly altered flat, pale mucosal areas. If any lesion was suspected of being premalignant, 0.3% indigo carmine was sprayed on it and biopsies were taken. They were immediately fixed in 10% formaldehyde and evaluated by hospital pathologists. If no premalignant lesions were suspected, but there were signs of chronic gastropathy (diffuse antral gastritis, diffuse corporal atrophic gastritis, or multifocal atrophic gastritis), systematic biopsies were taken, according to the Sydney protocol. 12
Statistical analysis
The lesion detection rate was calculated Descriptive statistics for frequencies and proportions were carried out. The chi-squared test was used for the categorical variables and the Student's t test for the quantitative variables, with a significance level of 0.05. The size of the effect (odds ratio with 95% CI) was also calculated. Sample size was established at 23 subjects per group through the proportions formula (␣ = 0.05, ␤ =0.2, power 0.8, ␦ = 0.4).
The study protocol was reviewed and accepted by the Research and Ethics Committee of the hospital (DI/16/107/03/032) and the Good Clinical Practice Guidelines were followed.
Results
There were 50 consecutive cases, mean patient age was 44.4 ± 3.34 years, 52% of the patients were women, and mean BMI was 27.6 ± 5.82 kg/cm 2 . Background histories: 58% of the patients took PPIs, 22% were alcoholics, and 8% were smokers. There were no differences in relation to age (p = 0.92) or BMI (p = 0.16) between groups. Endoscopic image quality for the morphologic differentiation of premalignant lesions was satisfactory in all the cases. No differences in the endoscopic image quality were observed between groups (p = 0.817). Mean duration (minutes) of the mucosal examination was significantly longer with SACE (12.8 ± 2.6, 95% CI: 12.09-13.51 versus 9.6 ± 2.42, 95% CI: 8.88-10.31; p = 0.0001) ( Table 2 ). Endoscopic findings (histologic confirmation): 18% (9/50) of the patients had normal mucosa, 20% (10/50) had chronic gastritis associated with H. pylori, 6% (3/50) had reactive gastritis, and 56% (28/50) had chronic gastritis. Six cases of intestinal metaplasia with no dysplasia (figs. 2 and 3) and one case of poorly differentiated adenocarcinoma (diffuse, according to the Lauren classification) that presented as a flat, ulcerated lesion ( fig. 4 , Table 3 ) were detected. The detection rate for premalignant lesions and gastric cancer was 14%. The most frequent region and areas with lesions were the antrum and lesser curvature. Sensitivity (Sn), specificity (Sp), positive predictive value (PPV), negative predictive value (NPV), and diagnostic accuracy were 100, 95, 80, 100, and 96%, respectively, for SACE. Sn, Sp, PPV, NPV, and diagnostic accuracy were 100, 45, 20, 100, and 52%, respectively, for conventional endoscopy. SACE was superior to conventional endoscopy for detecting pre-neoplastic lesions (p = 0.03; OR = 12) ( Table 4 ). Interobserver agreement was low (kappa 0.4). 
Discussion and conclusions
Gastric cancer is one of the main causes of cancer deaths, worldwide. Most cases are diagnosed at advanced stages and have a poor prognosis. Precancerous lesions include intestinal metaplasia and gastric atrophy. The authors of a Danish study showed an increased risk for cancer in patients with premalignant gastric lesions, reporting an annual incidence of gastric cancer of: 0.1% for patients with gastric atrophy, 0.25% for intestinal metaplasia, 0.6% for moderate dysplasia, and 0.6% for severe dysplasia, within 5 years from diagnosis. 4 Despite that prevalence, a global screening strategy does not exist. 3 In some high-prevalence zones, suggestions have been made to begin screening in men and women above 40 years of age, but that age range must be adjusted in specific populations, depending on gastric cancer incidence and individual risk factors. 13, 14 In non-endemic areas, it is recommended to begin screening at 40-45 years of age. 15 Endoscopy has become the method of choice in Japan and Korea, with reasonable cost-benefit. However, cost continues to be a problem in developing countries, in addition to the inherent risks of an invasive study. New imaging techniques, such as digital chromoendoscopy, magnification endoscopy, narrow band imaging, autofluorescence, confocal laser endomicroscopy, or endocystoscopy can improve premalignant lesion detection. 16---20 However, those techniques are not available at most endoscopy units. The detection of premalignant lesions depends on the knowledge and skill of the endoscopist, which is why the standardization of a technique and adequate training are important. 21 Hosokawa et al. reported false negative rates of up to 25.5% in early gastric cancer detection with endoscopy, and Aida et al. showed that gastric cancer lesions were undetected in a previous endoscopy in 23.1% of the cases. 7, 22 In a study that evaluated the factors related to the development of interval gastric cancer (cancer detected within 2 years of a negative endoscopy), the smallest lesions (1.3 cm vs 1.8 cm) and the presence of intestinal metaplasia were statistically significant in the multivariate analysis, 8 signifying that adequate endoscopic examination is necessary to detect those types of lesions.
The SACE protocol proposed by Emura et al. is a method for systematically inspecting the entire surface of the upper gastrointestinal tract based on the sequential photo-documentation of partially overlapped images, using an endoluminal alphanumeric-coded nomenclature for 8 regions and 28 areas of the digestive tract. It incorporates a simple system of coordinates based on the identification of certain natural axes, walls, curvatures, and anatomic reference points (Table 1, fig. 1 ). The effectiveness of the technique was demonstrated in a screening study on healthy, average-risk volunteers between 40 and 70 years of age, in which 0.3% (2/650) of the patients were diagnosed with early gastric cancer. 22 The SACE system has not been evaluated in the Mexican population. Ideally, a screening test should include intraluminal premedication, high-definition equipment, digital chromoendoscopy, and endoscopists with visual experience in image identification. 23 In the present case series, premedication was carried out with dimethicone or acetylcysteine to remove the adhered mucus and foam produced by secretions, which favored adequate evaluation of the gastric mucosal surface. The 2 preparations were analyzed (data not shown) and the dimethicone group had better endoscopic image quality. Conventional chromoendoscopy with indigo carmine dye (at 0.3%), which is non-absorbable and non-toxic, has shown superior detection of pre-neoplastic lesions and a facility for characterizing the lesions, their edges, and size. 23 In our study, there was a 14% prevalence of premalignant lesions and early gastric cancer, which is lower than that reported in populations considered to have high prevalence, such as Colombia (30%). 9 It was similar to prevalence reported in countries like Turkey (13%). 24 Mexico is regarded as a population with a low prevalence of intestinal metaplasia and gastric cancer. Both endoscopic techniques were efficacious for detecting cases (100%), but there was a high false positive rate (95% Sn vs 45% Sn) and a very low PPV (80 vs 20%) with the conventional method. The SACE technique was more effective than the conventional method in detecting premalignant lesions and early gastric cancer (p = 0.003; OR = 12; 95% CI). The limitations of our study were the low prevalence of those types of lesions in the study population, not having used highdefinition endoscopes to characterize the lesions, and low interobserver agreement. In addition, it was not a cross-over study with the patient as his or her own control to determine the rate of undetected lesions with the two techniques. The strengths of our study were based on its methodology (crosssectional design with randomized assignation). To the best of our knowledge, this is the only screening study evaluating the performance of SACE in Mexico. Ideally, endoscopic centers should utilize high-definition equipment and electronic chromoendoscopy to screen average-risk and high-risk subjects for gastric cancer. Nevertheless, systematic evaluation is a tool that can have a significant impact on lesion omission and interval cancer reduction.
In conclusion, SACE and conventional endoscopy were both effective in detecting premalignant lesions, but the alphanumeric-coded system significantly reduced the false positive rate.
